News

Medigene presented paths to potential neoantigen-based TCR-therapies

SHOW RELEASE

Medigene publishes preliminary financial results for the financial year 2018

SHOW RELEASE

Medigene presents poster on in vitro evaluation of TCR efficacy and toxicity at AACR

SHOW RELEASE

Medigene announces dosing of first patient in Phase I/II trial with TCR therapy MDG1011 for various blood cancers

SHOW RELEASE

Medigene presents development strategies for TCR therapies at CAR-TCR Summit Europe

SHOW RELEASE

European Patent covering TCR library suitable for the development of neoantigen-specific TCRs

SHOW RELEASE

Medigene participates at upcoming conferences

SHOW RELEASE

Medigene appoints Axel-Sven Malkomes as CFO/CBDO

SHOW RELEASE

Medigene participates at four upcoming conferences

SHOW RELEASE

Additional European patent granted for Medigene's DC vaccine platform

SHOW RELEASE

Medigene Licenses Co-stimulator to Enhance TCR Therapies for Solid Tumors

SHOW RELEASE

Medigene publishes topline interim data from ongoing Phase I/II clinical trial with DC vaccines in AML patients

SHOW RELEASE

Medigene participates at further upcoming conferences

SHOW RELEASE

Academic partner Oslo University Hospital presented clinical data on compassionate use of AML DC vaccine at ASH

SHOW RELEASE

Medigene participates at further upcoming conferences

SHOW RELEASE